⭐ Recognized by FeedSpot: #12 Best Anesthesiology Blog Worldwide

Uncategorized Published - 3 July, 2015    By - Dr Clemens
Postoperative recovery after anesthesia in morbidly obese patients: a systematic review and meta-analysis of randomized controlled trials.

Authors: Liu FL et al; Can J Anaesth. 2015 May PURPOSE: Obese patients present a challenge to safe general anesthesia because of impaired cardiopulmonary physiology and increased risks of aspiration and acute upper airway obstruction. Since studies are lacking regarding the postoperative effects on recovery from general anesthesia in morbidly obese patients, we conducted a systematic […]

Read More
Uncategorized Published - 3 July, 2015    By - Dr Clemens
FDA warns that Maquet’s anesthesia system could lead to a fatal stop in ventilation

Troubled Maquet’s woes continue. On the heels of a permanent injunction from the Department of Justice that resulted in the halt of manufacturing at one of its facilities, the suspension of 5 of its devices from the market and a $6 million fine, the FDA just warned practitioners that the company’s Flow-i Anesthesia Systems have a problem that […]

Read More
Uncategorized Published - 3 July, 2015    By - Dr Clemens
Does Brain Stimulation Help Treat Low Back Pain?

Authors: Luedtke K et al., BMJ 2015 350:h1640 A study of transcranial stimulation preceding behavioral cognitive therapy does not support the effectiveness of this procedure for the treatment of low back pain. Chronic low back pain is a frequent and costly problem for which few interventions are effective. Chronic low back pain is characterized by a number […]

Read More
Uncategorized Published - 2 July, 2015    By - Dr Clemens
Readmission Location Linked to Post-Surgical Mortality Rates

Patients with complications after major surgery are 26% more likely to survive if they return to the hospital where they had their operation, researchers find. Patients with complications after major surgery have better survival odds if they’re readmitted to the same hospital where the surgery was performed, throwing into doubt the assumption that travel long […]

Read More
Uncategorized Published - 2 July, 2015    By - Dr Clemens
Reversing Dabigatran-Induced Anticoagulation

Authors: Pollack CV Jr et al., N Engl J Med 2015 Jun 22 Idarucizumab immediately reversed dabigatran-induced increases in clotting variables without causing serious adverse events. Dabigatran is a direct thrombin inhibitor that is approved for the prevention of stroke in atrial fibrillation and for the treatment of venous thromboembolism. Bleeding is usually managed by discontinuing the drug or, […]

Read More